Extract from the Register of European Patents

EP About this file: EP3581223

EP3581223 - SYSTEMS FOR AUTOMATICALLY ADMINISTERING MEDICATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.05.2025
Database last updated on 26.03.2026
FormerThe patent has been granted
Status updated on  07.06.2024
FormerGrant of patent is intended
Status updated on  14.02.2024
FormerExamination is in progress
Status updated on  23.10.2020
FormerRequest for examination was made
Status updated on  25.09.2020
FormerThe application has been published
Status updated on  15.11.2019
Most recent event   Tooltip18.07.2025Lapse of the patent in a contracting state
New state(s): IT
published on 20.08.2025  [2025/34]
Applicant(s)For all designated states
UCB Biopharma SRL
Allée de la Recherche 60
1070 Brussels / BE
[2024/28]
Former [2020/02]For all designated states
UCB Biopharma SRL
Allé de la Recherche 60
1070 Brussels / BE
Former [2019/51]For all designated states
UCB Biopharma SPRL
Allée de la Recherche, 60
1070 Brussels / BE
Inventor(s)01 / MCLOUGHLIN, Martin John
UCB Celltech
208 Bath Road
Slough, Berkshire SL1 3WE / GB
02 / LEE, Alex
c/o Oxo
601 West 26th Street, Suite 1050
New York, NY 10001 / US
03 / FORMOSA, Dan
c/o Smart Design
601 West 26th Street 1820
New York, NY 100001 / US
04 / VORDENBERG, Steven
Vordenberg Design Studio
2 Twillight Farm Lane
Amherst, NH 03031 / US
05 / VICARI, Joern
c/o Smart Dedign
601 West 26th Street 1820
New York, NY 10001 / US
06 / FREITAG, Eric
c/o Smart Design
601 West 26th Street 1820
New York, NY 10001 / US
07 / KONTORVICH, Boris
c/o Smart Design
601 West 26th Street 1820
New York, NY 10001 / US
 [2024/11]
Former [2019/51]01 / MCLOUGHLIN, Martin John
UCB Celltech
208 Bath Road
Slough, Berkshire SL1 3WE / GB
02 / LEE, Alex
c/o Oxo
601 West 26th Street, Suite 1050
New York, 10001 / US
03 / FORMOSA, Dan
c/o Smart Design
601 West 26th Street 1820
New York, 100001 / US
04 / VORDENBERG, Steven
Vordenberg Design Studio
2 Twillight Farm Lane
Amherst, New Hampshire 03031 / US
05 / VICARI, Joern
c/o Smart Dedign
601 West 26th Street 1820
New York, NY 10001 / US
06 / FREITAG, Eric
c/o Smart Design
601 West 26th Street 1820
New York, NY 10001 / US
07 / KONTORVICH, Boris
c/o Smart Design
601 West 26th Street 1820
New York, NY 10001 / US
Representative(s)UCB Intellectual Property
c/o UCB Biopharma SRL
Intellectual Property Department
Allée de la Recherche 60
1070 Brussels / BE
[2024/28]
Former [2019/51]UCB Intellectual Property
c/o UCB Biopharma SPRL
Intellectual Property Department
Allée de la Recherche 60
1070 Brussels / BE
Application number, filing date19183793.920.07.2009
[2019/51]
Priority number, dateUS200813526208P18.07.2008         Original published format: US 13526208 P
US200819255108P18.09.2008         Original published format: US 19255108 P
[2019/51]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP3581223
Date:18.12.2019
Language:EN
[2019/51]
Type: A3 Search report 
No.:EP3581223
Date:18.03.2020
Language:EN
[2020/12]
Type: B1 Patent specification 
No.:EP3581223
Date:10.07.2024
Language:EN
[2024/28]
Search report(s)(Supplementary) European search report - dispatched on:EP17.02.2020
ClassificationIPC:A61M5/31, A61M5/32, A61M5/20, // A61M5/00
[2019/51]
CPC:
A61M5/3204 (EP,US); A61M5/3137 (EP,US); A61M5/3202 (EP,US);
A61M5/3213 (US); A61M2005/312 (US); A61M2005/3215 (EP,US);
A61M5/2033 (EP,US); A61M5/3134 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2020/44]
Former [2019/51]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
Extension statesAL18.09.2020
BA18.09.2020
RS18.09.2020
TitleGerman:SYSTEME ZUR AUTOMATISCHEN VERABREICHUNG VON MEDIKATION[2019/51]
English:SYSTEMS FOR AUTOMATICALLY ADMINISTERING MEDICATION[2019/51]
French:SYSTÈMES D'ADMINISTRATION AUTOMATIQUE DE MÉDICAMENT[2019/51]
Examination procedure31.07.2020Amendment by applicant (claims and/or description)
18.09.2020Examination requested  [2020/44]
18.09.2020Date on which the examining division has become responsible
22.10.2020Despatch of a communication from the examining division (Time limit: M04)
26.01.2021Reply to a communication from the examining division
12.05.2022Despatch of a communication from the examining division (Time limit: M04)
04.07.2022Reply to a communication from the examining division
15.02.2024Communication of intention to grant the patent
28.05.2024Fee for grant paid
28.05.2024Fee for publishing/printing paid
28.05.2024Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP09784750.3  / EP2326371
Opposition(s)11.04.2025No opposition filed within time limit [2025/25]
Fees paidRenewal fee
04.11.2019Renewal fee patent year 03
04.11.2019Renewal fee patent year 04
04.11.2019Renewal fee patent year 05
04.11.2019Renewal fee patent year 06
04.11.2019Renewal fee patent year 07
04.11.2019Renewal fee patent year 08
04.11.2019Renewal fee patent year 09
04.11.2019Renewal fee patent year 10
04.11.2019Renewal fee patent year 11
31.07.2020Renewal fee patent year 12
02.08.2021Renewal fee patent year 13
01.08.2022Renewal fee patent year 14
31.07.2023Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipSM10.07.2024
IT20.07.2024
[2025/34]
Former [2025/21]SM10.07.2024
Documents cited:Search[A] GB2438590  (CILAG GMBH INT et al.)
 [A] GB2424836  (CILAG AG INT et al.) [A] 11 * figures 1-5 * * page 5, line 1 - page 9, line 4 *
 [A] WO2005115508  (CILAG AG INT et al.) [A] 11 * figures 1-9 * * page 5, line 1 - page 7, line 5 *
by applicantWO2005070481
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.